Home >> January, 2008

Alfacell Releases Update on ONCONASE Trial

Posted on: Thursday, January 31st, 2008 in: Asbestos Cancer News

Alfacell Corporation of Somerset, NJ released updated results today for its ONCONASE Phase IIIb trial.
According to a press release by the company, 311 “evaluable events” (patient deaths) have occurred in the Phase IIIb clinical trial of ONCONASE, designated for the treatment of patients with unresectable (inoperable) malignant mesothelioma. Enrollment in the ONCONASE Phase IIIb clinical […]

No Comments